Question follow-through · 6143

Healthwatch

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of transferring the functions of Healthwatch into Government or NHS bodies on patient representation; and what safeguards he will put in place to

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
2 Jun 2026
Target answer date
4 Jun 2026
Answer
9 Jun 2026 · 7 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 2 Jun 2026

    Question tabled

    To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of transferring the functions of Healthwatch into Government or NHS bodies on patient representation; and what safeguards he will put in place to

  2. 4 Jun 2026

    Target answer date

    Date supplied by the official written-questions record.

  3. 9 Jun 2026

    Answer published

    An impact assessment has been undertaken and published alongside the introduction of the Health Bill 2026. It outlines the non-monetised benefits, including the streamlining of the landscape and legislation, avoiding duplication of activity, and increased...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Bile Duct Cancer

8 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department has taken to identify the causes of the increase in the (a) incidence and (b) mortality rates of cholangiocarcinoma (bile duct cancer) in England.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Bile Duct Cancer: Research

8 Jun 2026 · To ask the Secretary of State for Health and Social Care, what funding has been allocated by (a) his Department, (b) the National Institute for Health and Care Research and (c) other publicly funded bodies for research into cholangiocarcinoma in each of t

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Bile Duct Cancer: Diagnosis

8 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the early detection and diagnosis of cholangiocarcinoma; and if he will consider developing specific clinical guidance or awareness initiatives for he

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Primary Care: Digital Technology

8 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment has been made of the potential impact of digital-first systems, including SMS-based appointment booking and online triage platforms, on patient access to NHS primary care services;

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Dementia

29 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the Modern Service Framework for Frailty and Dementia establishes care co-ordination as a minimum national expectation for people living with dementia, and if

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Dementia: Palliative Care

29 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether he plans to ensure that the Modern Service Framework for Palliative and End of Life Care recognises dementia as a life-limiting condition that requires a constant palliative approach from d

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Hospices: Finance

6 Jul 2026 · To ask the Secretary of State for Health and Social Care, what revenue funding his Department will provide to adult hospices in England in 2026/27; and when that funding will be confirmed.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Hospices

6 Jul 2026 · To ask the Secretary of State for Health and Social Care, when the new framework for the commissioning and funding of hospice services by integrated care boards will be published; and whether it will be in force before 1 April 2027.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Hospices

6 Jul 2026 · To ask the Secretary of State for Health and Social Care, whether his Department will reimburse hospices in England for the increase in employer National Insurance contributions introduced in April 2025.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Hospices

6 Jul 2026 · To ask the Secretary of State for Health and Social Care, what information his Department holds on the proportion of the operating costs of (a) The Myton Hospices and (b) The Shakespeare Hospice is met by NHS Coventry and Warwickshire; and what assessment

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Hospices

6 Jul 2026 · To ask the Secretary of State for Health and Social Care, how the move of care from hospital to community set out in the 10 Year Health Plan will be funded for hospices providing community and hospice-at-home care.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Pancreatic Cancer

7 Jul 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to improve access to clinical trials for patients with pancreatic cancer by ensuring that eligible patients are automatically identified and referred to appropriate clinical